Prelude Therapeutics Incorporated · NASDAQ:PRLD
Shah Rajeev M. reported 1 trade in Prelude Therapeutics Incorporated shares (Form 4)
Traded Apr 27, 2026 · Filed Apr 28, 2026
On Apr 27, 2026, Shah Rajeev M. (10% owner) reported 1 trade in Prelude Therapeutics Incorporated shares, leaving 6,475,882 shares. Filed Apr 28, 2026 (Form 4).
- Shares
- 1,407,000 shares
- Holding after
- 6,475,882 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 27, 2026 | Common Stock | Other | 1,407,000 | 6,475,882 | Indirect |
Source
Related
- Prelude Therapeutics Incorporated
- Shah Rajeev M.
- Prelude Therapeutics Incorporated shareholders
- Schedule 13G · Soleus Capital Management, L.P. · Jul 8, 2026
- Schedule 13G · Ra Capital Management, L.P. · Apr 28, 2026
- Form 4 · Bonita David P · Apr 23, 2026
- Form 4 · OrbiMed Genesis GP LLC · Apr 23, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Apr 23, 2026